Ozempic vs Wegovy: What's the Difference?
Verdict Summary
Ozempic and Wegovy both contain Semaglutide. The difference is FDA indication and maximum dose — Wegovy is approved for weight management at higher doses.
Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →
At a Glance
| Dimension | Ozempic | Wegovy |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| FDA Indication | Type 2 diabetes | Chronic weight management |
| Maximum Dose | 2 mg/week | 2.4 mg/week |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| Average Weight Loss | ~6–9% (diabetes dose) | ~10–15% (obesity dose) |
| Insurance Coverage | Often covered for T2D | Variable coverage for obesity |
Ozempic Deep Dive
Ozempic (Semaglutide 0.5–2 mg) is FDA-approved for Type 2 diabetes management. It improves glycemic control, reduces cardiovascular risk, and produces significant weight loss as a secondary benefit. Many physicians prescribe Ozempic off-label for weight management, though the maximum approved dose is lower than Wegovy.
Wegovy Deep Dive
Wegovy (Semaglutide 2.4 mg) is FDA-approved specifically for chronic weight management in adults with BMI ≥27 with weight-related comorbidities or BMI ≥30. It uses the same Semaglutide molecule as Ozempic but at a higher maximum dose (2.4 mg vs 2 mg), which produces greater average weight loss.
How to Choose
Choose Ozempic if…
- •You have Type 2 diabetes as the primary indication
- •Your insurance covers Ozempic but not Wegovy
- •You are using it primarily for glycemic control with weight loss as a secondary benefit
Choose Wegovy if…
- •Weight loss is your primary goal
- •You do not have Type 2 diabetes
- •You want the maximum approved Semaglutide dose
Consider Both If…
The active ingredient is identical — the choice is primarily driven by your diagnosis, insurance coverage, and desired dose. Consult your physician.
Frequently Asked Questions
More Comparisons
BPC-157 vs TB-500
BPC-157 excels at localized tendon, ligament, and gut healing. TB-500 is better for systemic muscle recovery and widespread inflammation.
Semaglutide vs Tirzepatide
Tirzepatide produces greater average weight loss in clinical trials. Semaglutide has a longer post-market safety record. Both are excellent options.
Ipamorelin vs CJC-1295
Ipamorelin and CJC-1295 work through complementary mechanisms and are almost always used together rather than as alternatives.
Mounjaro vs Zepbound
Mounjaro and Zepbound both contain Tirzepatide. Mounjaro is approved for Type 2 diabetes; Zepbound for obesity. The active ingredient is identical.
Selank vs Semax
Selank is primarily anxiolytic — it reduces anxiety and improves mood. Semax is primarily a cognitive enhancer — it boosts focus, memory, and BDNF. They are frequently combined.
Epithalon vs GHK-Cu
Epithalon targets cellular aging through telomere maintenance. GHK-Cu addresses visible aging through collagen synthesis and tissue remodeling. They work through complementary mechanisms.